Compare QSI & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QSI | USNA |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 317.0M |
| IPO Year | N/A | 1996 |
| Metric | QSI | USNA |
|---|---|---|
| Price | $0.90 | $17.59 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 125.9K |
| Earning Date | 03-03-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.58 |
| Revenue | N/A | ★ $1,060,902,000.00 |
| Revenue This Year | $196.35 | $3.89 |
| Revenue Next Year | $229.03 | $6.22 |
| P/E Ratio | ★ N/A | $29.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.83 | $16.80 |
| 52 Week High | $3.10 | $38.32 |
| Indicator | QSI | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 43.01 | 37.87 |
| Support Level | N/A | $16.80 |
| Resistance Level | $1.11 | $18.11 |
| Average True Range (ATR) | 0.06 | 0.63 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 33.77 | 26.04 |
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.